Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions

<b>: </b>It is now established that adipose tissue, skeletal muscle, and heart are endocrine organs and secrete in normal and in pathological conditions several molecules, called, respectively, adipokines, myokines, and cardiokines. These secretory proteins constitute a closed network th...

Full description

Bibliographic Details
Main Authors: Pamela Senesi, Livio Luzi, Ileana Terruzzi
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/21/8372
id doaj-14619f2562ff42959c8a5c4e128d7673
record_format Article
spelling doaj-14619f2562ff42959c8a5c4e128d76732020-11-25T04:07:16ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-11-01218372837210.3390/ijms21218372Adipokines, Myokines, and Cardiokines: The Role of Nutritional InterventionsPamela Senesi0Livio Luzi1Ileana Terruzzi2Department of Biomedical Sciences for Health, Università degli Studi di Milano, 20131 Milan, ItalyDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, 20131 Milan, ItalyDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, 20131 Milan, Italy<b>: </b>It is now established that adipose tissue, skeletal muscle, and heart are endocrine organs and secrete in normal and in pathological conditions several molecules, called, respectively, adipokines, myokines, and cardiokines. These secretory proteins constitute a closed network that plays a crucial role in obesity and above all in cardiac diseases associated with obesity. In particular, the interaction between adipokines, myokines, and cardiokines is mainly involved in inflammatory and oxidative damage characterized obesity condition. Identifying new therapeutic agents or treatment having a positive action on the expression of these molecules could have a key positive effect on the management of obesity and its cardiac complications. Results from recent studies indicate that several nutritional interventions, including nutraceutical supplements, could represent new therapeutic agents on the adipo-myo-cardiokines network. This review focuses the biological action on the main adipokines, myokines and cardiokines involved in obesity and cardiovascular diseases and describe the principal nutraceutical approaches able to regulate leptin, adiponectin, apelin, irisin, natriuretic peptides, and follistatin-like 1 expression.https://www.mdpi.com/1422-0067/21/21/8372cardiovascular diseasesmetabolic syndromeobesitynutraceuticalsadipokinesmyokines
collection DOAJ
language English
format Article
sources DOAJ
author Pamela Senesi
Livio Luzi
Ileana Terruzzi
spellingShingle Pamela Senesi
Livio Luzi
Ileana Terruzzi
Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions
International Journal of Molecular Sciences
cardiovascular diseases
metabolic syndrome
obesity
nutraceuticals
adipokines
myokines
author_facet Pamela Senesi
Livio Luzi
Ileana Terruzzi
author_sort Pamela Senesi
title Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions
title_short Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions
title_full Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions
title_fullStr Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions
title_full_unstemmed Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions
title_sort adipokines, myokines, and cardiokines: the role of nutritional interventions
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2020-11-01
description <b>: </b>It is now established that adipose tissue, skeletal muscle, and heart are endocrine organs and secrete in normal and in pathological conditions several molecules, called, respectively, adipokines, myokines, and cardiokines. These secretory proteins constitute a closed network that plays a crucial role in obesity and above all in cardiac diseases associated with obesity. In particular, the interaction between adipokines, myokines, and cardiokines is mainly involved in inflammatory and oxidative damage characterized obesity condition. Identifying new therapeutic agents or treatment having a positive action on the expression of these molecules could have a key positive effect on the management of obesity and its cardiac complications. Results from recent studies indicate that several nutritional interventions, including nutraceutical supplements, could represent new therapeutic agents on the adipo-myo-cardiokines network. This review focuses the biological action on the main adipokines, myokines and cardiokines involved in obesity and cardiovascular diseases and describe the principal nutraceutical approaches able to regulate leptin, adiponectin, apelin, irisin, natriuretic peptides, and follistatin-like 1 expression.
topic cardiovascular diseases
metabolic syndrome
obesity
nutraceuticals
adipokines
myokines
url https://www.mdpi.com/1422-0067/21/21/8372
work_keys_str_mv AT pamelasenesi adipokinesmyokinesandcardiokinestheroleofnutritionalinterventions
AT livioluzi adipokinesmyokinesandcardiokinestheroleofnutritionalinterventions
AT ileanaterruzzi adipokinesmyokinesandcardiokinestheroleofnutritionalinterventions
_version_ 1724429370953564160